Semler Scientific (SMLR) Tops Q2 EPS by 7c

Semler Scientific (NASDAQ: SMLR) reported Q2 EPS of $0.75, $0.07 better than the analyst estimate of $0.68. Revenue for the quarter came in at $18.6 million versus the consensus estimate of $16 million.

For earnings history and earnings-related data on Semler Scientific (SMLR) click here.

You May Also Be Interested In

• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Incyte acquires Vega Therapeutics for $1.25B upfront
• Prestige Consumer Healthcare closes LaCorium deal, prices $400M notes